PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
PetMed Express (PETS) Misses Q4 EPS by 6c, Misses on Revenue
June 2, 2026 4:09 PM EDTPetMed Express (NASDAQ: PETS) reported Q4 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $42.8 million versus the consensus estimate of $52 million.
For earnings history and earnings-related data on PetMed Express (PETS) click here.
... More